Prediction of Clostridium Difficile Infection Recurrence and Risk-Based Heterogeneity of Treatment Effect of Vnacomycin vs Fidaxomicin.

Alraddadi, Basem.


  • Abstract: Despite successful therapy for Clostridium Difficile Infection (CDI), a significant number of patients will experience a recurrence. We aimed to develop a predictive model for recurrent CDI and to compare the efficacy of fidaxomicin and vancomycin in different risk groups. We included patients enrolled in two phase 3 clinical trials, comparing the efficacy and safety of fidaxomicin vs va... read more
This object is in collection Corporate name Permanent URL
Component ID:
To Cite:
DCA Citation Guide    EndNote